What is tgf β

Morsut, L. Vincent, D. Bardeesy, N. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.

Ozdamar, B. Viloria-Petit, A. Yi, J. Morrell, N. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Foletta, V. Lee-Hoeflich, S. Park, K. Holm, T. Mu, Y.

Non-Smad signaling pathways. Cell Tissue Res. Thiery, J. Epithelial—mesenchymal transitions in development and disease. Bruna, A. Cancer Cell 11 , — Ikushima, H. Cell Stem Cell 5 , — Cancer Cell 15 , — Shows that canonical SMAD signalling in the context of glioma cells drives expression of pluripotency cytokine LIF and that this promotes tumour reinitiation. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

Davis, B. Cell 39 , — Nature , 56—61 Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Ying, Q. Liu, F. Brabletz, S. EMBO Rep. Derynck, R. Tan, E. Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. Thuault, S. Nawshad, A. Cell Sci.

Samavarchi-Tehrani, P. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7 , 64—77 McDonald, O. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nature Struct. Takahashi, K. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Li, R. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

Cell Stem Cell 7 , 51—63 Ichida, J. Maherali, N. Roberts, A. Cytokine Growth Factor Rev. Yang, L. Trends Immunol. Li, M. Littman, D. Th17 and regulatory T cells in mediating and restraining inflammation. Zhou, L. Chen, C. Cell , 19—32 Arany, P. Smad3 deficiency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure.

Guasch, G. Cancer Cell 12 , — Labelle, M. Direct signaling between platelets and cancer cells induces an epithelial—mesenchymal-like transition and promotes metastasis. Cancer Cell 20 , — Sethi, N. Cancer Cell 19 , — Mohammad, K. Anido, J. Cancer Cell 18 , — Download references. The author would like to thank the members of his laboratory for their contributions and critical reading the manuscript.

You can also search for this author in PubMed Google Scholar. A phenotypic change that is characteristic of some developing tissues and certain forms of cancer. J Clin Invest — Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics. Mol Cell Biol 29 — Genes Develop 14 — Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.

Cancer Res 73 — The B56 family of protein phosphatase 2A PP2A regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem —9. Fibrogenesis Tissue Repair 3 Mol Endocrinol 19 —9. EMBO J 25 — Prostate 39 — Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 10 —7.

Neoplasia 13 — PLoS One 6 :e Cell Calcium 53 — Int J Oncol 30 — Inhibitory Smad7: emerging roles in health and disease. Curr Mol Pharmacol 4 — Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner. Mol Cancer Res 10 — PLoS Genet 9 :e Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.

Genes Dev 20 — TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology : —8. Breitkopf-Heinlein, K. BMP-9 interferes with liver regeneration and promotes liver fibrosis. Gut 66, — Campbell, C. Myostatin inhibitor ACE treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial.

Muscle Nerve 55, — Chen, J. Development of novel activin-targeted therapeutics. Specific targeting of TGF-beta family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.

Elevated expression of activins promotes muscle wasting and cachexia. Chen, Y. Clouthier, D. Coffey, R. Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. Crawford, S. Cell 93, — Dadlani, H. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle.

Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study. Care R Delaney, K. The role of TGF-beta1 during skeletal muscle regeneration. Cell Biol. Dendooven, A. Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Denholm, E. Expression and secretion of transforming growth factor-beta by bleomycin-stimulated rat alveolar macrophages.

PubMed Abstract Google Scholar. Dennler, S. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. Ebefors, K. Role of glomerular proteoglycans in IgA nephropathy. Fan, J. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Ferguson, M. Lancet , — Gabbiani, G.

The myofibroblast in wound healing and fibrocontractive diseases. Goumenos, D. Transforming growth factor-beta 1 and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.

Nephron 87, — Grygielko, E. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. Hamrick, M. Recombinant myostatin GDF-8 propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury.

Trauma 69, — Hardy, C. The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology. Harrison, C. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-beta superfamily ligands. Growth Fact. Hermida, N. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.

Hocevar, B. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. Hua, X. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. Ignotz, R. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. Google Scholar. Inman, G. Jiang, D. Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan Ketteler, M.

Increased expression of transforming growth factor-beta in renal disease. Khan, S. Enhanced bioactive myocardial transforming growth factor-beta in advanced human heart failure. Li, J. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes Metab.

Li, S. Li, R. Role of bone morphogenetic protein-7 in renal fibrosis. Li, Z. Myostatin directly regulates skeletal muscle fibrosis. Lijnen, P. Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts. Methods Find. Induction of cardiac fibrosis by transforming growth factor-beta 1. This leads to inhibition of MM cell growth, survival, drug resistance and migration[ ].

Higher levels of this cytokine mean lower levels of normal Ig resulting in immune impairment[ ]. It is broadly intertwined with other signaling pathways. Moreover, it is involved in cancerogenesis of solid tumors as well as hematological malignancies. The tumor suppressor activities are widely described as anti-proliferative and apoptotic effects. Cell Signal. Google Scholar. N Engl J Med. Proc Natl Acad Sci.

PubMed Google Scholar. Roles in Caenorhabditis elegans development. Trends Genet. Protein Sci. EMBO J. Nat Genet. J Biol Chem. Purification from human platelets and structural characterization. Gleizes PE, Beavis RC, Mazzieri R, Shen B, Rifkin DB: Identification and characterization of an eight-cysteine repeat of the latent transforming growth factorbetabinding protein-1 that mediates bonding to the latent transforming growth factorbeta1.

J Cell Biol. Kojima S, Nara K, Rifkin DB: Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB: Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation ofplasminogen activator activity. J Immunol. Sato Y, Rifkin DB: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule byplasmin during co-culture.

Yu Q, Stamenkovic I: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.

Mol Endocrinol. Domain structure of the receptor. Br J Haematol. BJU Int. Specialized binding regions fortransforming growth factor-beta and inhibin A. Cancer Res. Annu Rev Biophys Biomol Struct. Reviews on Cancer. CAS Google Scholar. Osteoarthr Cartil. Annu Rev Cell Dev Biol. Mol Cell. Nat Cell Biol. Cell Res. Curr Opin Cell Biol.

Gene Structure and Expression. Int J Biochem Cell Biol. J Cell Sci. Mol Biol Cell. Breast Cancer Res. Exp Cell Res. Nat Rev Cancer. Pangas SA, Matzuk MM: Genetic models for transforming growth factor beta superfamily signaling in ovarian follicle development. Mol Cell Endocrinol. J Neurosurg. Mol Cell Biol. Iavarone A, Massague J: E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest.

Cytokine Growth Factor Rev. Teicher BA: Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev.

Biochem J. Mareel M, Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Trends Immunol. Microbes Infect. Immunol Invest. Korpal M, Kang Y: Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.

Eur J Cancer.